Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,640.00
-160.00 (-2.05%)
At close: Oct 10, 2025

Ahn-Gook Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
290,775271,116233,676205,389163,534143,364
Upgrade
Other Revenue
----0--
Upgrade
290,775271,116233,676205,389163,534143,364
Upgrade
Revenue Growth (YoY)
15.17%16.02%13.77%25.59%14.07%-8.01%
Upgrade
Cost of Revenue
106,113103,21993,10579,10962,51658,471
Upgrade
Gross Profit
184,661167,896140,571126,279101,01884,893
Upgrade
Selling, General & Admin
151,500145,430121,343102,05283,15764,021
Upgrade
Research & Development
17,33113,25912,25512,95717,32816,993
Upgrade
Operating Expenses
171,912161,219135,509116,899102,10284,942
Upgrade
Operating Income
12,7496,6785,0619,381-1,084-49.1
Upgrade
Interest Expense
-3,090-3,002-142.75-160.41-116.83-756.89
Upgrade
Interest & Investment Income
303.53463.68388.54407.43335.82971.68
Upgrade
Earnings From Equity Investments
-2,3891,352-1,641-1,6452,6131,780
Upgrade
Currency Exchange Gain (Loss)
-62.7668.82-79.74-82.27133.07-302.34
Upgrade
Other Non Operating Income (Expenses)
-717.151,453-258.15336.26-246.68-1,431
Upgrade
EBT Excluding Unusual Items
6,7957,0133,3288,2371,634212.8
Upgrade
Gain (Loss) on Sale of Investments
362.05230.47921.68-889.552,033625.7
Upgrade
Gain (Loss) on Sale of Assets
-259.5813,21617.1328.25138.65-60.42
Upgrade
Asset Writedown
-219.98-219.98----
Upgrade
Pretax Income
6,67720,2394,2677,3753,805778.08
Upgrade
Income Tax Expense
1,1313,8963,269496.1461.492,166
Upgrade
Earnings From Continuing Operations
5,54616,343998.286,8793,744-1,388
Upgrade
Net Income to Company
5,54616,343998.286,8793,744-1,388
Upgrade
Minority Interest in Earnings
557.51502.28291.85-3.95195.5672.98
Upgrade
Net Income
6,10316,8451,2906,8753,939-1,315
Upgrade
Net Income to Common
6,10316,8451,2906,8753,939-1,315
Upgrade
Net Income Growth
-60.24%1205.72%-81.24%74.54%--
Upgrade
Shares Outstanding (Basic)
111111111111
Upgrade
Shares Outstanding (Diluted)
111111111113
Upgrade
Shares Change (YoY)
---0.12%-0.65%-9.44%10.37%
Upgrade
EPS (Basic)
537.021482.18113.51604.21343.93-114.79
Upgrade
EPS (Diluted)
6.001482.00113.51604.00343.93-114.79
Upgrade
EPS Growth
-99.56%1205.57%-81.21%75.62%--
Upgrade
Free Cash Flow
29,943-70,972-6,802-1,143-2,563-12,929
Upgrade
Free Cash Flow Per Share
2634.58-6244.63-598.47-100.42-223.77-1022.23
Upgrade
Dividend Per Share
440.000440.000----
Upgrade
Gross Margin
63.51%61.93%60.16%61.48%61.77%59.21%
Upgrade
Operating Margin
4.38%2.46%2.17%4.57%-0.66%-0.03%
Upgrade
Profit Margin
2.10%6.21%0.55%3.35%2.41%-0.92%
Upgrade
Free Cash Flow Margin
10.30%-26.18%-2.91%-0.56%-1.57%-9.02%
Upgrade
EBITDA
21,74514,37610,08414,3113,4234,634
Upgrade
EBITDA Margin
7.48%5.30%4.32%6.97%2.09%3.23%
Upgrade
D&A For EBITDA
8,9957,6985,0234,9304,5074,683
Upgrade
EBIT
12,7496,6785,0619,381-1,084-49.1
Upgrade
EBIT Margin
4.38%2.46%2.17%4.57%-0.66%-0.03%
Upgrade
Effective Tax Rate
16.94%19.25%76.61%6.73%1.62%278.43%
Upgrade
Advertising Expenses
-11,3375,5435,7765,4823,935
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.